Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133


Synaptotoxicity in Alzheimer's disease involved a dysregulation of actin cytoskeleton dynamics through cofilin 1 phosphorylation.

Rush T, Martinez-Hernandez J, Dollmeyer M, Lise Frandemiche M, Borel E, Boisseau S, Jacquier-Sarlin M, Buisson A.

J Neurosci. 2018 Oct 19. pii: 1409-18. doi: 10.1523/JNEUROSCI.1409-18.2018. [Epub ahead of print]


A key function for microtubule-associated-protein 6 in activity-dependent stabilisation of actin filaments in dendritic spines.

Peris L, Bisbal M, Martinez-Hernandez J, Saoudi Y, Jonckheere J, Rolland M, Sebastien M, Brocard J, Denarier E, Bosc C, Guerin C, Gory-Fauré S, Deloulme JC, Lanté F, Arnal I, Buisson A, Goldberg Y, Blanchoin L, Delphin C, Andrieux A.

Nat Commun. 2018 Sep 17;9(1):3775. doi: 10.1038/s41467-018-05869-z.


Bowel wall healing assessed using magnetic resonance imaging predicts sustained clinical remission and decreased risk of surgery in Crohn's disease.

Buisson A, Hordonneau C, Goutorbe F, Allimant C, Goutte M, Reymond M, Pereira B, Bommelaer G.

J Gastroenterol. 2018 Aug 30. doi: 10.1007/s00535-018-1505-8. [Epub ahead of print]


Male gender, active smoking and previous intestinal resection are risk factors for post-operative endoscopic recurrence in Crohn's disease: results from a prospective cohort study.

Auzolle C, Nancey S, Tran-Minh ML, Buisson A, Pariente B, Stefanescu C, Fumery M, Marteau P, Treton X, Hammoudi N; REMIND Study Group Investigators, Jouven X, Seksik P, Allez M.

Aliment Pharmacol Ther. 2018 Nov;48(9):924-932. doi: 10.1111/apt.14944. Epub 2018 Aug 20.


Risk of serious infection in healthcare workers with inflammatory bowel disease: a case-control study of the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID).

Gagnière C, Bourrier A, Seksik P, Gornet JM, DeWit O, Nancey S, Altwegg R, Abitbol V, Laharie D, Reenaers C, Buisson A, Pariente B, Viennot S, Vuitton L, Stefanescu C, Marteau P, Bouguen G, Cosnes J, Amiot A; GETAID INFOPRO study group.

Aliment Pharmacol Ther. 2018 Oct;48(7):713-722. doi: 10.1111/apt.14926. Epub 2018 Aug 2.


Whole exome sequencing in three families segregating a pediatric case of sarcoidosis.

Calender A, Rollat Farnier PA, Buisson A, Pinson S, Bentaher A, Lebecque S, Corvol H, Abou Taam R, Houdouin V, Bardel C, Roy P, Devouassoux G, Cottin V, Seve P, Bernaudin JF, Lim CX, Weichhart T, Valeyre D, Pacheco Y, Clement A, Nathan N; in the frame of GSF (Groupe Sarcoïdose France).

BMC Med Genomics. 2018 Mar 6;11(1):23. doi: 10.1186/s12920-018-0338-x.


IBD-INFO Questionnaire: A Multicenter French Up-to-Date Survey of Patient Knowledge in Inflammatory Bowel Disease.

Danion P, Buisson A, Roblin X, Mathieu N, Charlois AL, Borgerding JN, Williet N, Del Tedesco E, Flourié B, Nancey S, Boschetti G.

Inflamm Bowel Dis. 2018 Apr 23;24(5):943-952. doi: 10.1093/ibd/izx073.


How to strengthen the presence of patients in health technology assessments conducted by the health authorities.

Mamzer MF, Dubois S, Saout C; participants of Round Table «Topical Subject» of Giens XXXIII, Albin N, Béhier JM, Buisson A, Diebolt V, Delaitre O, Duguet C, Fagon JY, Gaillard S, Le Jeunne C, Mazars R, Micallef J, Nabarette H, Piazza L, Raynaud C, Varoqueaux N.

Therapie. 2018 Feb;73(1):95-105. doi: 10.1016/j.therap.2017.11.004. Epub 2017 Dec 21. French.


Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis.

Mak WY, Buisson A, Andersen MJ Jr, Lei D, Pekow J, Cohen RD, Kahn SA, Pereira B, Rubin DT.

Dig Dis Sci. 2018 May;63(5):1294-1301. doi: 10.1007/s10620-018-4980-0. Epub 2018 Feb 22.


Faecal calprotectin and magnetic resonance imaging in detecting Crohn's disease endoscopic postoperative recurrence.

Baillet P, Cadiot G, Goutte M, Goutorbe F, Brixi H, Hoeffel C, Allimant C, Reymond M, Obritin-Guilhen H, Magnin B, Bommelaer G, Pereira B, Hordonneau C, Buisson A.

World J Gastroenterol. 2018 Feb 7;24(5):641-650. doi: 10.3748/wjg.v24.i5.641.


Systematic Review With Meta-Analysis: Anti-TNF Therapy in Refractory Pouchitis and Crohn's Disease-Like Complications of the Pouch After Ileal Pouch-Anal Anastomosis Following Colectomy for Ulcerative Colitis.

Huguet M, Pereira B, Goutte M, Goutorbe F, Dubois A, Bommelaer G, Buisson A.

Inflamm Bowel Dis. 2018 Jan 18;24(2):261-268. doi: 10.1093/ibd/izx049.


Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's Disease.

D'Haens G, Vermeire S, Lambrecht G, Baert F, Bossuyt P, Pariente B, Buisson A, Bouhnik Y, Filippi J, Vander Woude J, Van Hootegem P, Moreau J, Louis E, Franchimont D, De Vos M, Mana F, Peyrin-Biroulet L, Brixi H, Allez M, Caenepeel P, Aubourg A, Oldenburg B, Pierik M, Gils A, Chevret S, Laharie D; GETAID.

Gastroenterology. 2018 Apr;154(5):1343-1351.e1. doi: 10.1053/j.gastro.2018.01.004. Epub 2018 Jan 6.


Long-term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience.

Wils P, Bouhnik Y, Michetti P, Flourie B, Brixi H, Bourrier A, Allez M, Duclos B, Serrero M, Buisson A, Amiot A, Fumery M, Roblin X, Peyrin-Biroulet L, Filippi J, Bouguen G, Abitbol V, Coffin B, Simon M, Laharie D, Pariente B; Groupe d'Etude Thérapeutique des Affections Inflammatoires du Tube Digestif (GETAID).

Aliment Pharmacol Ther. 2018 Mar;47(5):588-595. doi: 10.1111/apt.14487. Epub 2018 Jan 8.


Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort.

Tadbiri S, Peyrin-Biroulet L, Serrero M, Filippi J, Pariente B, Roblin X, Buisson A, Stefanescu C, Trang-Poisson C, Altwegg R, Marteau P, Vaysse T, Bourrier A, Nancey S, Laharie D, Allez M, Savoye G, Gilletta C, Gagniere C, Vuitton L, Viennot S, Aubourg A, Pelletier AL, Bouguen G, Abitbol V, Fumery M, Claudepierre P, Bouhnik Y, Amiot A; GETAID OBSERV-IBD study group.

Aliment Pharmacol Ther. 2018 Feb;47(4):485-493. doi: 10.1111/apt.14419. Epub 2017 Dec 18.


Predictive performance of four frailty screening tools in community-dwelling elderly.

Bongue B, Buisson A, Dupre C, Beland F, Gonthier R, Crawford-Achour É.

BMC Geriatr. 2017 Nov 10;17(1):262. doi: 10.1186/s12877-017-0633-y.


Location of Mutation in BRCA2 Gene and Survival in Patients with Ovarian Cancer.

Labidi-Galy SI, Olivier T, Rodrigues M, Ferraioli D, Derbel O, Bodmer A, Petignat P, Rak B, Chopin N, Tredan O, Heudel PE, Stuckelberger S, Meeus P, Meraldi P, Viassolo V, Ayme A, Chappuis PO, Stern MH, Houdayer C, Stoppa-Lyonnet D, Buisson A, Golmard L, Bonadona V, Ray-Coquard I.

Clin Cancer Res. 2018 Jan 15;24(2):326-333. doi: 10.1158/1078-0432.CCR-17-2136. Epub 2017 Oct 30.


Inflammatory gastrointestinal diseases associated with PD-1 blockade antibodies.

Collins M, Michot JM, Danlos FX, Mussini C, Soularue E, Mateus C, Loirat D, Buisson A, Rosa I, Lambotte O, Laghouati S, Chaput N, Coutzac C, Voisin AL, Soria JC, Marabelle A, Champiat S, Robert C, Carbonnel F.

Ann Oncol. 2017 Nov 1;28(11):2860-2865. doi: 10.1093/annonc/mdx403.


Efficacy and safety of golimumab in Crohn's disease: a French national retrospective study.

Martineau C, Flourié B, Wils P, Vaysse T, Altwegg R, Buisson A, Amiot A, Pineton de Chambrun G, Abitbol V, Fumery M, Hébuterne X, Viennot S, Laharie D, Beaugerie L, Nancey S, Sokol H; Goli-Crohn Study Group.

Aliment Pharmacol Ther. 2017 Dec;46(11-12):1077-1084. doi: 10.1111/apt.14371. Epub 2017 Oct 13.


GluN2B Subunit Labeling with Fluorescent Probes and High-Resolution Live Imaging.

Perrio C, Nicole O, Buisson A.

Methods Mol Biol. 2017;1677:171-183. doi: 10.1007/978-1-4939-7321-7_9.


Magnetic resonance index of activity (MaRIA) and Clermont score are highly and equally effective MRI indices in detecting mucosal healing in Crohn's disease.

Buisson A, Pereira B, Goutte M, Reymond M, Allimant C, Obritin-Guilhen H, Bommelaer G, Hordonneau C.

Dig Liver Dis. 2017 Nov;49(11):1211-1217. doi: 10.1016/j.dld.2017.08.033. Epub 2017 Aug 31.


Involvement of CRF2 signaling in enterocyte differentiation.

Ducarouge B, Pelissier-Rota M, Powell R, Buisson A, Bonaz B, Jacquier-Sarlin M.

World J Gastroenterol. 2017 Jul 28;23(28):5127-5145. doi: 10.3748/wjg.v23.i28.5127.


Transmural Healing and MRI Remission: New Promising Therapeutic Targets in Crohn's Disease.

Buisson A, Hordonneau C, Deepak P.

Inflamm Bowel Dis. 2017 Sep;23(9):E44-E45. doi: 10.1097/MIB.0000000000001219. No abstract available.


Fecal Matrix Metalloprotease-9 and Lipocalin-2 as Biomarkers in Detecting Endoscopic Activity in Patients With Inflammatory Bowel Diseases.

Buisson A, Vazeille E, Minet-Quinard R, Goutte M, Bouvier D, Goutorbe F, Pereira B, Barnich N, Bommelaer G.

J Clin Gastroenterol. 2018 Aug;52(7):e53-e62. doi: 10.1097/MCG.0000000000000837.


TRPA1 channels promote astrocytic Ca2+ hyperactivity and synaptic dysfunction mediated by oligomeric forms of amyloid-β peptide.

Bosson A, Paumier A, Boisseau S, Jacquier-Sarlin M, Buisson A, Albrieux M.

Mol Neurodegener. 2017 Jul 6;12(1):53. doi: 10.1186/s13024-017-0194-8.


One-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study.

Amiot A, Serrero M, Peyrin-Biroulet L, Filippi J, Pariente B, Roblin X, Buisson A, Stefanescu C, Trang-Poisson C, Altwegg R, Marteau P, Vaysse T, Bourrier A, Nancey S, Laharie D, Allez M, Savoye G, Moreau J, Vuitton L, Viennot S, Aubourg A, Pelletier AL, Bouguen G, Abitbol V, Gagniere C, Bouhnik Y; OBSERV-IBD study group and the GETAID.

Aliment Pharmacol Ther. 2017 Aug;46(3):310-321. doi: 10.1111/apt.14167. Epub 2017 Jun 8.


Comparative Acceptability and Perceived Clinical Utility of Monitoring Tools: A Nationwide Survey of Patients with Inflammatory Bowel Disease.

Buisson A, Gonzalez F, Poullenot F, Nancey S, Sollellis E, Fumery M, Pariente B, Flamant M, Trang-Poisson C, Bonnaud G, Mathieu S, Thevenin A, Duruy M, Filippi J, Lʼhopital F, Luneau F, Michalet V, Genès J, Achim A, Cruzille E, Bommelaer G, Laharie D, Peyrin-Biroulet L, Pereira B, Nachury M, Bouguen G; ACCEPT study group.

Inflamm Bowel Dis. 2017 Aug;23(8):1425-1433. doi: 10.1097/MIB.0000000000001140.


Nasal high flow in management of children with status asthmaticus: a retrospective observational study.

Baudin F, Buisson A, Vanel B, Massenavette B, Pouyau R, Javouhey E.

Ann Intensive Care. 2017 Dec;7(1):55. doi: 10.1186/s13613-017-0278-1. Epub 2017 May 22.


Migraine prevalence in inflammatory bowel disease patients: A tertiary-care centre cross-sectional study.

Moisset X, Bommelaer G, Boube M, Ouchchane L, Goutte M, Dapoigny M, Dallel R, Guttmann A, Clavelou P, Buisson A.

Eur J Pain. 2017 Oct;21(9):1550-1560. doi: 10.1002/ejp.1056. Epub 2017 May 16.


The amyloid-β oligomer Aβ*56 induces specific alterations in neuronal signaling that lead to tau phosphorylation and aggregation.

Amar F, Sherman MA, Rush T, Larson M, Boyle G, Chang L, Götz J, Buisson A, Lesné SE.

Sci Signal. 2017 May 9;10(478). pii: eaal2021. doi: 10.1126/scisignal.aal2021.


Medical Therapies for Stricturing Crohn's Disease: Efficacy and Cross-Sectional Imaging Predictors of Therapeutic Failure.

Campos C, Perrey A, Lambert C, Pereira B, Goutte M, Dubois A, Goutorbe F, Dapoigny M, Bommelaer G, Hordonneau C, Buisson A.

Dig Dis Sci. 2017 Jun;62(6):1628-1636. doi: 10.1007/s10620-017-4572-4. Epub 2017 Apr 11.


Risk of Rectal Neoplasia after Colectomy and Ileorectal Anastomosis for Ulcerative Colitis.

Uzzan M, Kirchgesner J, Oubaya N, Amiot A, Gornet JM, Seksik P, Nancey S, Cotte E, Allez M, Boschetti G, Laharie D, de Angelis N, Nachury M, Pelletier AL, Abitbol V, Fumery M, Brouquet A, Buisson A, Altwegg R, Cosnes J, Panis Y, Treton X.

J Crohns Colitis. 2017 Aug 1;11(8):930-935. doi: 10.1093/ecco-jcc/jjx027.


What score should be used for evaluation of Crohn's disease severity using magnetic resonance imaging?

Buisson A, Hordonneau C, Goutte M, Bommelaer G.

J Gastroenterol. 2017 May;52(5):652-653. doi: 10.1007/s00535-016-1301-2. Epub 2016 Dec 29. No abstract available.


Postoperative Complications after Ileocecal Resection in Crohn's Disease: A Prospective Study From the REMIND Group.

Fumery M, Seksik P, Auzolle C, Munoz-Bongrand N, Gornet JM, Boschetti G, Cotte E, Buisson A, Dubois A, Pariente B, Zerbib P, Chafai N, Stefanescu C, Panis Y, Marteau P, Pautrat K, Sabbagh C, Filippi J, Chevrier M, Houze P, Jouven X, Treton X, Allez M; REMIND study group investigators.

Am J Gastroenterol. 2017 Feb;112(2):337-345. doi: 10.1038/ajg.2016.541. Epub 2016 Dec 13.


Macrophages Versus Escherichia coli: A Decisive Fight in Crohn's Disease.

Buisson A, Bringer MA, Barnich N, Vazeille E.

Inflamm Bowel Dis. 2016 Dec;22(12):2943-2955. Review.


Effectiveness and Safety of Vedolizumab Induction Therapy for Patients With Inflammatory Bowel Disease.

Amiot A, Grimaud JC, Peyrin-Biroulet L, Filippi J, Pariente B, Roblin X, Buisson A, Stefanescu C, Trang-Poisson C, Altwegg R, Marteau P, Vaysse T, Bourrier A, Nancey S, Laharie D, Allez M, Savoye G, Moreau J, Gagniere C, Vuitton L, Viennot S, Aubourg A, Pelletier AL, Bouguen G, Abitbol V, Bouhnik Y; Observatory on Efficacy and of Vedolizumab in Patients With Inflammatory Bowel Disease Study Group; Groupe d'Etude Therapeutique des Affections Inflammatoires du tube Digestif.

Clin Gastroenterol Hepatol. 2016 Nov;14(11):1593-1601.e2. doi: 10.1016/j.cgh.2016.02.016. Epub 2016 Feb 22.


Anti-TNFα therapy for chronic inflammatory disease in kidney transplant recipients: Clinical outcomes.

Garrouste C, Anglicheau D, Kamar N, Bachelier C, Rivalan J, Pereira B, Caillard S, Aniort J, Gatault P, Soubrier M, Sayegh J, Colosio C, Buisson A, Thervet E, Bouvier N, Heng AE.

Medicine (Baltimore). 2016 Oct;95(41):e5108.


Ultrafast Singlet Energy Transfer in Porphyrin Dyads.

Dekkiche H, Buisson A, Langlois A, Karsenti PL, Ruhlmann L, Harvey PD, Ruppert R.

Inorg Chem. 2016 Oct 6. [Epub ahead of print]


Patient-reported Outcomes in a French Nationwide Survey of Inflammatory Bowel Disease Patients.

Williet N, Sarter H, Gower-Rousseau C, Adrianjafy C, Olympie A, Buisson A, Beaugerie L, Peyrin-Biroulet L.

J Crohns Colitis. 2017 Feb;11(2):165-174. doi: 10.1093/ecco-jcc/jjw145. Epub 2016 Aug 11.


Metal Linkage Effects on Ultrafast Energy Transfer.

Dekkiche H, Buisson A, Langlois A, Karsenti PL, Ruhlmann L, Ruppert R, Harvey P.

Chemistry. 2016 Jul 18;22(30):10484-93. doi: 10.1002/chem.201601322. Epub 2016 Jun 22.


Endoscopy-based management decreases the risk of postoperative recurrences in Crohn's disease.

Boucher AL, Pereira B, Decousus S, Goutte M, Goutorbe F, Dubois A, Gagniere J, Borderon C, Joubert J, Pezet D, Dapoigny M, Déchelotte PJ, Bommelaer G, Buisson A.

World J Gastroenterol. 2016 Jun 7;22(21):5068-78. doi: 10.3748/wjg.v22.i21.5068.


Myenteric plexitis is a risk factor for endoscopic and clinical postoperative recurrence after ileocolonic resection in Crohn's disease.

Decousus S, Boucher AL, Joubert J, Pereira B, Dubois A, Goutorbe F, Déchelotte PJ, Bommelaer G, Buisson A.

Dig Liver Dis. 2016 Jul;48(7):753-8. doi: 10.1016/j.dld.2016.02.023. Epub 2016 Mar 3.


Faecal chitinase 3-like 1 is a reliable marker as accurate as faecal calprotectin in detecting endoscopic activity in adult patients with inflammatory bowel diseases.

Buisson A, Vazeille E, Minet-Quinard R, Goutte M, Bouvier D, Goutorbe F, Pereira B, Barnich N, Bommelaer G.

Aliment Pharmacol Ther. 2016 May;43(10):1069-79. doi: 10.1111/apt.13585. Epub 2016 Mar 8.


Risk of Incident Cancer in Inflammatory Bowel Disease Patients Starting Anti-TNF Therapy While Having Recent Malignancy.

Poullenot F, Seksik P, Beaugerie L, Amiot A, Nachury M, Abitbol V, Stefanescu C, Reenaers C, Fumery M, Pelletier AL, Nancey S, Peyrin-Biroulet L, Bourreille A, Hébuterne X, Brixi H, Savoye G, Lourenço N, Altwegg R, Buisson A, Cazelles-Boudier C, Racine A, Vergniol J, Laharie D; le GETAID.

Inflamm Bowel Dis. 2016 Jun;22(6):1362-9. doi: 10.1097/MIB.0000000000000741.


Diffusion-weighted magnetic resonance enterocolonography in predicting remission after anti-TNF induction therapy in Crohn's disease.

Buisson A, Hordonneau C, Goutte M, Scanzi J, Goutorbe F, Klotz T, Boyer L, Pereira B, Bommelaer G.

Dig Liver Dis. 2016 Mar;48(3):260-6. doi: 10.1016/j.dld.2015.10.019. Epub 2015 Nov 22.


GipA Factor Supports Colonization of Peyer's Patches by Crohn's Disease-associated Escherichia Coli.

Vazeille E, Chassaing B, Buisson A, Dubois A, de Vallée A, Billard E, Neut C, Bommelaer G, Colombel JF, Barnich N, Darfeuille-Michaud A, Bringer MA.

Inflamm Bowel Dis. 2016 Jan;22(1):68-81. doi: 10.1097/MIB.0000000000000609.


Subcutaneous Ustekinumab Provides Clinical Benefit for Two-Thirds of Patients With Crohn's Disease Refractory to Anti-Tumor Necrosis Factor Agents.

Wils P, Bouhnik Y, Michetti P, Flourie B, Brixi H, Bourrier A, Allez M, Duclos B, Grimaud JC, Buisson A, Amiot A, Fumery M, Roblin X, Peyrin-Biroulet L, Filippi J, Bouguen G, Abitbol V, Coffin B, Simon M, Laharie D, Pariente B; Groupe d'Etude Thérapeutique des Affections Inflammatoires du Tube Digestif.

Clin Gastroenterol Hepatol. 2016 Feb;14(2):242-50.e1-2. doi: 10.1016/j.cgh.2015.09.018. Epub 2015 Sep 30.


Endoscopic Factors Influencing Fecal Calprotectin Value in Crohn's Disease.

Goutorbe F, Goutte M, Minet-Quinard R, Boucher AL, Pereira B, Bommelaer G, Buisson A.

J Crohns Colitis. 2015 Dec;9(12):1113-9. doi: 10.1093/ecco-jcc/jjv150. Epub 2015 Sep 7.


Diffusion-weighted magnetic resonance imaging is effective to detect ileocolonic ulcerations in Crohn's disease.

Buisson A, Hordonneau C, Goutte M, Boyer L, Pereira B, Bommelaer G.

Aliment Pharmacol Ther. 2015 Aug;42(4):452-60. doi: 10.1111/apt.13287. Epub 2015 Jun 18.


Detection of Dysplasia or Cancer in 3.5% of Patients With Inflammatory Bowel Disease and Colonic Strictures.

Fumery M, Pineton de Chambrun G, Stefanescu C, Buisson A, Bressenot A, Beaugerie L, Amiot A, Altwegg R, Savoye G, Abitbol V, Bouguen G, Simon M, Duffas JP, Hébuterne X, Nancey S, Roblin X, Leteurtre E, Bommelaer G, Lefevre JH, Brunetti F, Guillon F, Bouhnik Y, Peyrin-Biroulet L.

Clin Gastroenterol Hepatol. 2015 Oct;13(10):1770-5. doi: 10.1016/j.cgh.2015.04.185. Epub 2015 May 19.


What is the Role of Diffusion-weighted Imaging in Ileocolonic Crohn's Disease?

Buisson A, Hordonneau C, Goutte M, Bommelaer G.

Inflamm Bowel Dis. 2015 Jun;21(6):E9. doi: 10.1097/MIB.0000000000000415. No abstract available.

Supplemental Content

Loading ...
Support Center